Let me know when the data is updated again

RAMIREZ SAMPERIO GRISELDA ALICIA

Summary of sales of medicines and medical supplies

113 purchase as supplier for a total of 15 millones (14,951,617.203 ) between 2010 and 2012.

Annual evolution of purchase
Procedure type
Top buyers



Largest purchase



Total overcost

Overcost in MXN

216,961.9 pesos mexicanos

Overcost in %

17.1 %

Top products
Product Purchases Total amount Overcost in MXN Overcost in % Period
LOPERAMIDA 34 261,919.4 MXN 31,661.2 MXN 21.7 % 2010 - 2011
CLIOQUINOL 18 3.7 millones MXN 11,499.5 MXN 5.11 % 2011 - 2011
BROMOCRIPTINA 18 6.2 millones MXN 34,551.8 MXN 14.7 % 2010 - 2012
OXCARBAZEPINA 7 1.4 millones MXN 132.8 MXN 0.219 % 2010 - 2011
METFORMINA 6 1.4 millones MXN 7,233.6 MXN 3.55 % 2011 - 2011
VENLAFAXINA 5 776,177.2 MXN 20,953.7 MXN 1.94 % 2010 - 2011
METRONIDAZOL 3 16,547.7 MXN 5,972.8 MXN 57.9 % 2010 - 2011
FLUOXETINA 3 128,252.8 MXN 495 MXN 1.62 % 2010 - 2011
CITALOPRAM 3 385,814 MXN 0 MXN 0 % 2011 - 2011
ESPIRONOLACTONA 2 41,296.5 MXN 8,835.3 MXN 27.2 % 2012 - 2012

Summary of contract activity as supplier

1 contract as supplier for a total of 16,327.5 between 2012 and 2012.

Location

Country

México

GENERAL INFORMATION

Identifiers

RFC: RASG770608LW8

Date updated in QQW

8 de noviembre de 2019

Organization responsible for the import

PODER